Tracking the COVID-19 pandemic in Australia using genomics.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 06 07 2020
accepted: 17 08 2020
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 24 9 2020
Statut: epublish

Résumé

Genomic sequencing has significant potential to inform public health management for SARS-CoV-2. Here we report high-throughput genomics for SARS-CoV-2, sequencing 80% of cases in Victoria, Australia (population 6.24 million) between 6 January and 14 April 2020 (total 1,333 COVID-19 cases). We integrate epidemiological, genomic and phylodynamic data to identify clusters and impact of interventions. The global diversity of SARS-CoV-2 is represented, consistent with multiple importations. Seventy-six distinct genomic clusters were identified, including large clusters associated with social venues, healthcare and cruise ships. Sequencing sequential samples from 98 patients reveals minimal intra-patient SARS-CoV-2 genomic diversity. Phylodynamic modelling indicates a significant reduction in the effective viral reproductive number (R

Identifiants

pubmed: 32873808
doi: 10.1038/s41467-020-18314-x
pii: 10.1038/s41467-020-18314-x
pmc: PMC7462846
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4376

Subventions

Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : APP1105525
Pays : International
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : APP1174555
Pays : International

Références

Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
doi: 10.1038/s41586-020-2012-7
Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
doi: 10.1056/NEJMoa2001017
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25, 2000045 (2020).
pmcid: 6988269
Patel, R. et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: value of diagnostic testing for SARS–CoV-2/COVID-19. mBio 11, e00722–20 (2020).
doi: 10.1128/mBio.00722-20
Forster, P., Forster, L., Renfrew, C. & Forster, M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc. Natl Acad. Sci. USA 117, 9241–9243 (2020).
doi: 10.1073/pnas.2004999117
Stefanelli, P. et al. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Eurosurveillance 25, pii=2000305 (2020).
doi: 10.2807/1560-7917.ES.2020.25.13.2000305
Chan, J. F.-W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020).
doi: 10.1016/S0140-6736(20)30154-9
Sansone, M. et al. Extensive hospital in-ward clustering revealed by molecular characterization of influenza A virus infection. Clin. Infect. Dis. ciaa108 https://doi.org/10.1093/cid/ciaa108 (2020).
Poon, A. F. et al. Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study. Lancet HIV 3, e231–e238 (2016).
doi: 10.1016/S2352-3018(16)00046-1
Peters, P. J. et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. NEJM 375, 229–239 (2016).
doi: 10.1056/NEJMoa1515195
Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020).
doi: 10.1016/S0140-6736(20)30251-8
Pung, R. et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 10229, 1039–1046 (2020).
doi: 10.1016/S0140-6736(20)30528-6
Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology. Preprint at https://www.biorxiv.org/content/10.1101/2020.04.17.046086v1 (2020).
Department of Health & Human Services Victoria. Theoretical modelling to inform Victoria’s response to coronavirus (COVID-19). https://www.dhhs.vic.gov.au/theoretical-modelling-inform-victorias-response-coronavirus-covid-19 (2020).
Pybus O. G. et al. Preliminary analysis of SARS-CoV-2 importation and establishment of UK transmission lineages. Preprint at https://virological.org/t/preliminary-analysis-of-sars-cov-2-importation-establishment-of-uk-transmission-lineages/507 (2020).
Australian Government, Department of Foreign Affairs and Trade. COVID-19 advice for travellers. https://www.smartraveller.gov.au/COVID-19-australian-travellers (2020).
Moriarty, L. F. et al. Public health responses to COVID-19 outbreaks on cruise ships—worldwide, February-March 2020. MMWR 69, 347–352 (2020).
pubmed: 32214086
Zhan, M., Qin, Y., Xue, X. & Zhu, S. Death from COVID-19 of 23 health care workers in China. NEJM 382, 2267–2268 (2020).
doi: 10.1056/NEJMc2005696
Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. J. Am. Med. Assoc. 323, 1239–1242 (2020).
doi: 10.1001/jama.2020.2648
du Plessis, L. & Stadler, T. Getting to the root of epidemic spread with phylodynamic analysis of genomic data. Trends Microbiol. 23, 383–386 (2015).
doi: 10.1016/j.tim.2015.04.007
Rockett, R. J. et al. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modelling. Nat. Med. https://doi.org/10.1038/s41591-020-1000-7 (2020).
Wolfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469 (2020).
doi: 10.1038/s41586-020-2196-x
De Maio, N. et al. Issues with SARS-CoV-2 sequencing data. Virological https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473 (2020).
Caly, L. et al. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med. J. Aust. 212, 459–462 (2020).
doi: 10.5694/mja2.50569
ARTIC Network. ARTIC-nCoV2019 primer schemes (Github). https://github.com/artic-network/artic-ncov2019/tree/master/primer_schemes/nCoV-2019/V3 (2020).
Quick, J. nCoV-2019 sequencing protocol. https://doi.org/10.17504/protocols.io.bbmuik6w (2020).
Ragonnet-Cronin, M. et al. Automated analysis of phylogenetic clusters. BMC Bioinforma. 14, 317 (2013).
doi: 10.1186/1471-2105-14-317
Bouckaert, R. et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. J. PLoS Comp. Biol. 15, e1006650 (2019).
doi: 10.1371/journal.pcbi.1006650
Ho, S. Y. et al. Simulating and detecting autocorrelation of molecular evolutionary rates among lineages. Mol. Ecol. Resour. 15, 688–696 (2015).
doi: 10.1111/1755-0998.12320
Stadler, T., Kühnert, D., Bonhoeffer, S. & Drummond, A. J. Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV). Proc. Natl Acad. Sci. USA 110, 228–233 (2013).
doi: 10.1073/pnas.1207965110

Auteurs

Torsten Seemann (T)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Courtney R Lane (CR)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Norelle L Sherry (NL)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Sebastian Duchene (S)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Anders Gonçalves da Silva (A)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Leon Caly (L)

Victorian Infectious Diseases Reference Laboratory at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Michelle Sait (M)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Susan A Ballard (SA)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Kristy Horan (K)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Mark B Schultz (MB)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Tuyet Hoang (T)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Marion Easton (M)

Victorian Department of Health and Human Services, Melbourne, VIC, Australia.

Sally Dougall (S)

Victorian Department of Health and Human Services, Melbourne, VIC, Australia.

Timothy P Stinear (TP)

Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Julian Druce (J)

Victorian Infectious Diseases Reference Laboratory at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Mike Catton (M)

Victorian Infectious Diseases Reference Laboratory at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Brett Sutton (B)

Victorian Department of Health and Human Services, Melbourne, VIC, Australia.

Annaliese van Diemen (A)

Victorian Department of Health and Human Services, Melbourne, VIC, Australia.

Charles Alpren (C)

Victorian Department of Health and Human Services, Melbourne, VIC, Australia.

Deborah A Williamson (DA)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Victorian Infectious Diseases Reference Laboratory at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Benjamin P Howden (BP)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. bhowden@unimelb.edu.au.
Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. bhowden@unimelb.edu.au.
Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. bhowden@unimelb.edu.au.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH